“Hope” for the liver? Mechanistic insight into the role of the renin-angiotensin system in hepatic fibrosis

Authors

  • Gavin E. Arteel Ph.D.

    1. Department of Pharmacology and Toxicology and the James Graham Brown Cancer Center, University of Louisville Health Sciences Center, Louisville, KY
    Search for more papers by this author

Abstract

Angiotensin II (AngII) is a pro-oxidant and fibrogenic cytokine. We investigated the role of NADPH oxidase in AngII-induced effects in hepatic stellate cells (HSCs), a fibrogenic cell type. Human HSCs express mRNAs of key components of nonphagocytic NADPH oxidase. AngII phosphorylated p47phox, a regulatory subunit of NADPH oxidase, and induced reactive oxygen species formation via NADPH oxidase activity. AngII phosphorylated AKT and MAPKs and increased AP-1 DNA binding in a redox-sensitive manner. AngII stimulated DNA synthesis, cell migration, procollagen alpha1(I) mRNA expression, and secretion of TGF-beta1 and inflammatory cytokines. These effects were attenuated by N-acetylcysteine and diphenylene iodonium, an NADPH oxidase inhibitor. Moreover, AngII induced upregulation of genes potentially involved in hepatic wound-healing response in a redox-sensitive manner, as assessed by microarray analysis. HSCs isolated from p47phox−/− mice displayed a blunted response to AngII compared with WT cells. We also assessed the role of NADPH oxidase in experimental liver fibrosis. After bile duct ligation, p47phox−/− mice showed attenuated liver injury and fibrosis compared with WT counterparts. Moreover, expression of smooth muscle alpha-actin and expression of TGF-beta1 were reduced in p47phox−/− mice. Thus, NADPH oxidase mediates the actions of AngII on HSCs and plays a critical role in liver fibrogenesis.

Ancillary